Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

  1. Bykerk, V.P.
  2. Östör, A.J.K.
  3. Alvaro-Gracia, J.
  4. Pavelka, K.
  5. Ivorra, J.A.R.
  6. Graninger, W.
  7. Bensen, W.
  8. Nurmohamed, M.T.
  9. Krause, A.
  10. Bernasconi, C.
  11. Aassi, M.
  12. Sibilia, J.
Aldizkaria:
Clinical Rheumatology

ISSN: 1434-9949,  0770-3198

Argitalpen urtea: 2015

Alea: 34

Zenbakia: 3

Orrialdeak: 563-571

Mota: Artikulua

DOI: 10.1007/S10067-014-2857-Y GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus